Ibu Direkt Ratiopharm

Ibuprofen, the active ingredient in Ibu Direkt, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain, fever, and inflammation in adults and children as appropriate.

GNH USA supplies Ibu Direkt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibu Direkt (ibuprofen) works within the prostaglandin pathway to relieve common discomforts and inflammatory conditions. - Pain: provides analgesic relief for mild to moderate aches. - Fever: reduces elevated body temperature. - Inflammation: helps control swelling associated with musculoskeletal injuries or inflammatory disorders.

Adverse reactions may range from mild, transient symptoms to serious, potentially life‑threatening conditions.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache or dizziness. - Mild skin rash or itching. - Elevated blood pressure. - Diarrhoea.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. - Acute renal failure or worsening of chronic kidney disease. - Hepatotoxicity with elevated liver enzymes. - Thrombotic events in high‑risk cardiovascular patients. - Severe thrombocytopenia or blood dyscrasias.

Before using Ibu Direkt, consider the following safety measures. - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Use the lowest effective dose for the shortest duration needed. - Avoid in individuals with known hypersensitivity to ibuprofen or other NSAIDs. - Caution in renal or hepatic impairment: monitor function regularly. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can affect the activity of several other medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: additive risk of ulceration. - ACE inhibitors or ARBs: possible reduction in renal function. - Lithium: elevated lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce antihypertensive effect. - Methotrexate: decreased clearance leading to toxicity. - Antihypertensives: possible attenuation of blood pressure control. - SSRIs: modest increase in bleeding tendency. - Oral hypoglycemics: potential alteration of glucose control.